Pharmaceutical Prime Vendor Global GEN V Solicitation
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
DLA TROOP SUPPORT
Contract Value
Not provided
Codes & Classification
Solicitation Number
SPE2DX-24-R-0001_SOLICITATION
NAICS
325412 - Pharmaceutical Preparation Manufacturing
Classification Code
6505
Additional Details
The Defense Logistics Agency (DLA) Troop Support has issued a solicitation for the Pharmaceutical Prime Vendor Generation V (PPV-G GEN V) program, under procurement identifier SPE2DX-24-R-0001. This solicitation seeks to establish a contractual relationship with a qualified prime vendor capable of supporting the global pharmaceutical requirements of the Department of Defense and other federal agencies. The primary objective of this procurement is to ensure the reliable, efficient, and timely supply of pharmaceutical preparations to military and federal healthcare facilities worldwide.
The scope of the PPV-G GEN V program encompasses the procurement, warehousing, and distribution of a comprehensive range of pharmaceutical products, as classified under NAICS code 325412 (Pharmaceutical Preparation Manufacturing) and Product Service Code 6505. The selected contractor will be responsible for managing a robust supply chain that meets the stringent quality, security, and delivery standards required by federal healthcare operations. The intended outcome is to maintain uninterrupted access to critical medications and pharmaceutical supplies, thereby supporting the health and readiness of service members and beneficiaries.
Key requirements for this solicitation include the ability to source, manage, and distribute a wide array of pharmaceutical products on a global scale. Offerors must demonstrate proven capabilities in pharmaceutical logistics, inventory management, regulatory compliance, and customer service. The contract will require adherence to all applicable federal regulations and industry standards governing pharmaceutical preparation and distribution. Expected deliverables include the consistent fulfillment of pharmaceutical orders, comprehensive reporting, and responsive customer support throughout the contract period.
The contracting activity is managed by DLA Troop Support, a federal office located within the Department of Defense. Interested parties may direct inquiries to the primary contact, Catherine Gilbert, at [email protected] or 215-737-4778, or to the secondary contact, Lorinda Ferraiolo, at [email protected] or 215-737-7014. The solicitation is currently active, with a response deadline of August 7, 2024.
This procurement is classified as a solicitation and is posted on SAM.gov under Opportunity ID 71c0943a76414a9da4e0a8af604621aa. Offerors are encouraged to review all 28 attachments associated with the notice for detailed requirements, terms, and submission instructions. No set-aside requirements or special considerations are specified in the provided information.
Contractors with established expertise in pharmaceutical preparation manufacturing and global distribution are encouraged to evaluate this opportunity. The PPV-G GEN V program represents a significant, long-term contract supporting the critical mission of federal healthcare delivery, with requirements and expectations that will remain consistent throughout the contract lifecycle.
Documents28